top of page

High Risk Demographic Groups

Risk factors to look out for when prescribing opioids

something

Our Story

Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does, and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know.

If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers, and how you stand out from the crowd. Add a photo, gallery, or video for even more engagement.

Meet The Team

Image by @danilo.alvesd

Patients w Prior Nonfatal Overdose

  1. Although studies were not identified that directly addressed the risk for overdose among patients with prior nonfatal overdose who are prescribed opioids, based on clinical experience, experts thought that prior nonfatal overdose would substantially increase risk for future nonfatal or fatal opioid overdose. If patients experience nonfatal opioid overdose, clinicians should work with them to reduce opioid dosage and to discontinue opioids when possible (see Recommendation 7).

  2. If clinicians continue opioid therapy for chronic pain outside of active cancer, palliative, and end-of-life care in patients with prior opioid overdose, they should discuss increased risks for overdose with patients, carefully consider whether benefits of opioids outweigh substantial risks, and incorporate strategies to mitigate risk into the management plan, such as considering offering naloxone (see Offering Naloxone to Patients When Factors That Increase Risk for Opioid-Related Harms Are Present) and increasing frequency of monitoring (see Recommendation 7) when opioids are prescribed.

Our Clients

bottom of page